We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+23.32%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.26B
AUM Growth
+$63.8M
(+5.3%)
Cap. Flow
-$158M
Cap. Flow
% of AUM
-12.49%
Top 10 Holdings %
Top 10 Hldgs %
50.84%
Holding
38
New
4
Increased
5
Reduced
16
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$47.5M |
| 2 |
Zimmer Biomet
ZBH
|
+$25.2M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
+$8.61M |
| 4 |
Enphase Energy
ENPH
|
+$5.51M |
| 5 |
Nektar Therapeutics
NKTR
|
+$4.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FDC
First Data Corporation
FDC
|
+$45M |
| 2 |
CZR
Caesars Entertainment Corporation
CZR
|
+$26.7M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$19.5M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$18.8M |
| 5 |
Atara Biotherapeutics
ATRA
|
+$16.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.66% |
| 2 | Technology | 15.81% |
| 3 | Consumer Discretionary | 10.65% |
| 4 | Communication Services | 7.54% |
| 5 | Consumer Staples | 5.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
STAAR Surgical
STAA
$1.21B
| $17.6M | 1.39% |
514,105
| – | – |
|
27
Wave Life Sciences
WVE
$1.09B
| $15.4M | 1.22% |
397,090
+85,697
| +28% | +$3.48M |
|
|
PVG
28
DELISTED
PRETIUM RESOURCES INC.
PVG
| $14.1M | 1.12% |
1,651,328
| – | – |
|
|
CZR
29
DELISTED
Caesars Entertainment Corporation
CZR
| $12M | 0.95% |
1,377,004
-3,075,885
| -69% | -$26.7M |
|
|
GDEN
30
DELISTED
Golden Entertainment
GDEN
| $11.6M | 0.92% |
822,487
-460,268
| -36% | -$8.06M |
|
|
NVRO
31
DELISTED
NEVRO CORP.
NVRO
| $11.4M | 0.91% |
+183,141
| New | +$8.61M |
|
|
32
Enphase Energy
ENPH
$5.01B
| $6.69M | 0.53% |
+724,723
| New | +$5.51M |
|
33
DexCom
DXCM
$32.3B
| $6.11M | 0.48% |
205,208
-20,620
| -9% | -$725K |
|
34
Amneal Pharmaceuticals
AMRX
$5.84B
| – | – |
-1,021,420
| Closed | -$13.8M |
|
|
CSII
35
DELISTED
Cardiovascular Systems, Inc.
CSII
| – | – |
-536,128
| Closed | -$15.3M |
|
|
ALXN
36
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-200,049
| Closed | -$19.5M |
|
|
WCG
37
DELISTED
Wellcare Health Plans, Inc.
WCG
| – | – |
-79,816
| Closed | -$18.8M |
|
|
FDC
38
DELISTED
First Data Corporation
FDC
| – | – |
-2,658,994
| Closed | -$45M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q1 2019 Portfolio in Review
As of Q1 2019, Bridger Management held 38 positions worth $1.26B, up 5.3% from $1.2B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Bridger Management withdrew a net $158M in Q1 2019, closing 5 positions and reducing 16 holdings. Its most notable exit was First Data Corporation, an estimated $45M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 38% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Bridger Management opened a new position in Labcorp worth $50.6M.
- Bridger Management's largest Q1 2019 buy was Labcorp: 385,364 shares worth $50.6M.
- Bridger Management added most to Nektar Therapeutics in Q1 2019, an estimated $4.11M increase.
- Bridger Management's biggest Q1 2019 reduction was Caesars Entertainment Corporation, cutting an estimated $26.7M.
- Bridger Management fully exited First Data Corporation in Q1 2019, selling an estimated $45M.
- Bridger Management's ten largest holdings make up 51% of its $1.26B portfolio in Q1 2019.
- Bridger Management opened 4 new positions and closed 5 in Q1 2019.
- Bridger Management's portfolio value rose 5.3% quarter-over-quarter to $1.26B.
Based on Bridger Management's 13F filing for Q1 2019, filed 15 May 2019.